Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features.
Saved in:
| Title: | Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features. |
|---|---|
| Authors: | Iacobucci I; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Zeng AGX; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Gao Q; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Garcia-Prat L; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Baviskar P; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Shah S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Murison A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Voisin V; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Chan-Seng-Yue M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Cheng C; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Qu C; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Bailey C; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Lear M; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Witkowski MT; Department of Pediatrics-HemeOnc and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Zhou X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA., Zaldivar Peraza A; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA., Gangwani K; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA., Advani AS; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Luger SM; Abramson Cancer Center and the Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA, USA., Litzow MR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rowe JM; Rambam Health Care Campus and Technion, Israel Institute of Technology, Haifa, Israel.; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel., Paietta EM; Department of Oncology, Montefiore Medical Center, Bronx, NY, USA., Stock W; Hematopoiesis and Hematological Malignancies Program, University of Chicago, Chicago, IL, USA., Dick JE; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. john.dick@uhn.ca.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. john.dick@uhn.ca., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. charles.mullighan@stjude.org.; Center of Excellence for Leukemia Studies, St. Jude Children's Research Hospital, Memphis, TN, USA. charles.mullighan@stjude.org. |
| Source: | Nature cancer [Nat Cancer] 2025 Jul; Vol. 6 (7), pp. 1242-1262. Date of Electronic Publication: 2025 Jun 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
